PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹3,393 Cr | ₹2,645 Cr | ₹3,812 Cr | ₹2,903 Cr | ₹2,560 Cr |
What is the latest Total Non-Current Liabilities ratio of PIRAMAL PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹3,393 Cr |
| Mar2024 | ₹2,645 Cr |
| Mar2023 | ₹3,812 Cr |
| Mar2022 | ₹2,903 Cr |
| Mar2021 | ₹2,560 Cr |
How is Total Non-Current Liabilities of PIRAMAL PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,393 Cr | 28.29 | |
| Mar2024 | ₹2,645 Cr | -30.62 | |
| Mar2023 | ₹3,812 Cr | 31.33 | |
| Mar2022 | ₹2,903 Cr | 13.37 | |
| Mar2021 | ₹2,560 Cr | - | |
Compare Total Non-Current Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹21,519.7 Cr | -2.2% | 12.8% | -25.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -2.2% |
12.8% |
-25.9% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses